{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,4]],"date-time":"2026-11-04T06:21:32Z","timestamp":1793773292773,"version":"4.6.1"},"reference-count":84,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2022,12,16]],"date-time":"2022-12-16T00:00:00Z","timestamp":1671148800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Endocrinol."],"abstract":"<jats:sec><jats:title>Introduction<\/jats:title><jats:p>Diabetes mellitus (DM) has been proved to contribute to multiple comorbidities that are risk factors for abdominal aortic aneurysm (AAA). Remarkably, evidences from epidemiologic studies have demonstrated a negative association between the two disease states. On the other hand, hyperglycemic state was linked to post-operative morbidities following AAA repair. This review aims to provide a thorough picture on the double-edged nature of DM and major hypoglycemic medications on prevalence, growth rate and rupture of AAA, as well as DM-associated prognosis post AAA repair.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>We performed a comprehensive search in electronic databases to look for literatures demonstrating the association between DM and AAA. The primary focus of the literature search was on the impact of DM on the morbidity, enlargement and rupture rate, as well as post-operative complications of AAA. The role of antidiabetic medications was also explored.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>Retrospective epidemiological studies and large database researches associated the presence of DM with decreased prevalence, slower expansion and limited rupture rate of AAA. Major hypoglycemic drugs exert similar protective effect as DM against AAA by targeting pathological hallmarks involved in AAA formation and progression, which were demonstrated predominantly by animal studies. Nevertheless, presence of DM or postoperative hyperglycemia was linked to poorer short-term and long-term prognosis, primarily due to greater risk of infection, longer duration of hospital stays and death.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusion<\/jats:title><jats:p>While DM is a positive factor in the formation and progression of AAA, it is also associated with higher risk of negative outcomes following AAA repair. Concomitant use of antidiabetic medications may contribute to the protective mechanism of DM in AAA, but further studies are still warranted to explore their role following AAA repair.<\/jats:p><\/jats:sec>","DOI":"10.3389\/fendo.2022.1095608","type":"journal-article","created":{"date-parts":[[2022,12,16]],"date-time":"2022-12-16T05:17:25Z","timestamp":1671167845000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":23,"title":["Double-edged sword of diabetes mellitus for abdominal aortic aneurysm"],"prefix":"10.3389","volume":"13","author":[{"given":"Zijia","family":"Huang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huiling","family":"Su","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tiejun","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuwen","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2022,12,16]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1515\/jtim-2016-0008","article-title":"Aortic aneurysm","volume":"4","author":"Mathur","year":"2016","journal-title":"J Transl Int Med"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(12)61728-0","article-title":"Global and regional mortality from 235 causes of death for 20 age groups in 1990 and 2010: a systematic analysis for the global burden of disease study 2010","volume":"380","author":"Lozano","year":"2012","journal-title":"Lancet"},{"key":"B3","doi-asserted-by":"publisher","first-page":"3","DOI":"10.4103\/jwas.jwas_15_21","article-title":"Prevalence and epidemiological pattern of abdominal aortic aneurysms in Africa: A systematic review","volume":"10","author":"Ngetich E","year":"2020","journal-title":"J West Afr Coll Surg"},{"key":"B4","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1177\/1358863X211034574","article-title":"The role of dipeptidyl peptidase-IV in abdominal aortic aneurysm pathogenesis: A systematic review","volume":"27","author":"Ngetich","year":"2022","journal-title":"Vasc Med"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.1016\/j.avsg.2018.11.007","article-title":"Effect of diabetes on long-term mortality following abdominal aortic aneurysm repair: A systemic review and meta-analysis","volume":"64","author":"Huang","year":"2020","journal-title":"Ann Vasc Surg"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.1002\/dmrr.2585","article-title":"Advanced complicated diabetes mellitus is associated with a reduced risk of thoracic and abdominal aortic aneurysm rupture: a population-based cohort study","volume":"31","author":"Tsai","year":"2015","journal-title":"Diabetes Metab Res Rev"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejvs.2009.10.014","article-title":"Diabetes and the abdominal aortic aneurysm","volume":"39","author":"Shantikumar","year":"2010","journal-title":"Eur J Vasc Endovasc Surg"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.1016\/j.jdiacomp.2015.08.011","article-title":"Abdominal aortic aneurysms and diabetes mellitus","volume":"29","author":"Pafili","year":"2015","journal-title":"J Diabetes Complications."},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.3389\/fcvm.2021.769343","article-title":"Exploring the correlation and protective role of diabetes mellitus in aortic aneurysm disease","volume":"8","author":"Arun","year":"2021","journal-title":"Front Cardiovasc Med"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.1016\/j.artere.2018.01.001","article-title":"Diabetes mellitus as a protective factor of abdominal aortic aneurysm: Possible mechanisms","volume":"30","author":"Climent","year":"2018","journal-title":"Clin Investig Arterioscler"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.1159\/000490373","article-title":"Diabetes mellitus: Is it protective against aneurysm? a narrative review","volume":"141","author":"Patel","year":"2018","journal-title":"Cardiology"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.1136\/bmjopen-2016-012584","article-title":"Diverging effects of diabetes mellitus in patients with peripheral artery disease and abdominal aortic aneurysm and the role of advanced glycation end-products: ARTERY study - protocol for a multicentre cross-sectional study","volume":"7","author":"de Vos","year":"2017","journal-title":"BMJ Open"},{"key":"B13","doi-asserted-by":"publisher","first-page":"110","DOI":"10.1186\/s12933-021-01296-5","article-title":"Advanced glycation end-products, measured as skin autofluorescence, associate with vascular stiffness in diabetic, pre-diabetic and normoglycemic individuals: A cross-sectional study","volume":"20","author":"Birukov","year":"2021","journal-title":"Cardiovasc Diabetol"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.1177\/1479164118780799","article-title":"Diabetes mellitus and abdominal aortic aneurysms: A review of the mechanisms underlying the negative relationship","volume":"15","author":"Dattani","year":"2018","journal-title":"Diabetes Vasc Dis Res"},{"key":"B15","doi-asserted-by":"publisher","first-page":":927","DOI":"10.3390\/jcm9040927","article-title":"Calprotectin and receptor for advanced glycation end products as a potential biomarker in abdominal aortic aneurysm","volume":"9","author":"Hauzer","year":"2020","journal-title":"J Clin Med"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCULATIONAHA.114.012377","article-title":"Segmental aortic stiffening contributes to experimental abdominal aortic aneurysm development","volume":"131","author":"Raaz","year":"2015","journal-title":"Circulation"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCULATIONAHA.105.551572","article-title":"Matrix metalloproteinase-8 and -9 are increased at the site of abdominal aortic aneurysm rupture","volume":"113","author":"Wilson","year":"2006","journal-title":"Circulation"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejvs.2007.12.004","article-title":"Elevated plasma MMP1 and MMP9 are associated with abdominal aortic aneurysm rupture","volume":"35","author":"Wilson","year":"2008","journal-title":"Eur J Vasc Endovasc Surg"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.1161\/JAHA.115.003062","article-title":"Hyperglycemia suppresses calcium phosphate-induced aneurysm formation through inhibition of macrophage activation","volume":"5","author":"Tanaka","year":"2016","journal-title":"J Am Heart Assoc"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.1016\/j.atherosclerosis.2007.12.060","article-title":"Human proinsulin c-peptide reduces high glucose-induced proliferation and NF-kappaB activation in vascular smooth muscle cells","volume":"201","author":"Cifarelli","year":"2008","journal-title":"Atherosclerosis"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.3389\/fcvm.2021.732122","article-title":"Insulin resistance promotes the formation of aortic dissection by inducing the phenotypic switch of vascular smooth muscle cells","volume":"8","author":"Zheng","year":"2021","journal-title":"Front Cardiovasc Med"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.1161\/ATVBAHA.119.312787","article-title":"Role of vascular smooth muscle cell phenotypic switching and calcification in aortic aneurysm formation","volume":"39","author":"Petsophonsakul","year":"2019","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.1093\/cvr\/cvy174","article-title":"Diabetes and aortic aneurysm: current state of the art","volume":"114","author":"Raffort","year":"2018","journal-title":"Cardiovasc Res"},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.1152\/ajpcell.00608.2008","article-title":"Inherent differences in morphology, proliferation, and migration in saphenous vein smooth muscle cells cultured from nondiabetic and type 2 diabetic patients","volume":"297","author":"Madi","year":"2009","journal-title":"Am J Physiol Cell Physiol"},{"key":"B25","doi-asserted-by":"publisher","first-page":":942","DOI":"10.3390\/biom12070942","article-title":"The detrimental role of intraluminal thrombus outweighs protective advantage in abdominal aortic aneurysm pathogenesis: The implications for the anti-platelet therapy","volume":"12","author":"Ma","year":"2022","journal-title":"Biomolecules"},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.1016\/j.jvssci.2021.02.001","article-title":"Intraluminal thrombus: Innocent bystander or factor in abdominal aortic aneurysm pathogenesis","volume":"2","author":"Boyd","year":"2021","journal-title":"JVS Vasc Sci"},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.1152\/ajpheart.00620.2011","article-title":"Increased PAI-1 in females compared with males is protective for abdominal aortic aneurysm formation in a rodent model","volume":"302","author":"DiMusto","year":"2012","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.1111\/j.1538-7836.2007.02791.x","article-title":"Fibrinolysis in patients with an abdominal aortic aneurysm with special emphasis on rupture and shock","volume":"6","author":"Skagius E","year":"2008","journal-title":"J Thromb Haemost."},{"key":"B29","doi-asserted-by":"publisher","first-page":"9","DOI":"10.2310\/6670.2006.00008","article-title":"Intraluminal thrombus enhances proteolysis in abdominal aortic aneurysms","volume":"14","author":"Carrell","year":"2006","journal-title":"Vascular"},{"key":"B30","doi-asserted-by":"publisher","DOI":"10.1016\/j.surg.2010.05.014","article-title":"Hyperglycemia modulates plasminogen activator inhibitor-1 expression and aortic diameter in experimental aortic aneurysm disease","volume":"148","author":"Dua","year":"2010","journal-title":"Surgery"},{"key":"B31","doi-asserted-by":"publisher","DOI":"10.1067\/mva.2001.114813","article-title":"Association of intraluminal thrombus in abdominal aortic aneurysm with local hypoxia and wall weakening","volume":"34","author":"Vorp","year":"2001","journal-title":"J Vasc Surg"},{"key":"B32","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1016\/j.jvs.2012.07.003","article-title":"Intraluminal abdominal aortic aneurysm thrombus is associated with disruption of wall integrity","volume":"57","author":"Koole","year":"2013","journal-title":"J Vasc Surg"},{"key":"B33","doi-asserted-by":"publisher","DOI":"10.1016\/j.jvs.2020.03.046","article-title":"Evaluating the prevalence of abdominal aortic aneurysms in the united states through a national screening database","volume":"73","author":"Summers","year":"2021","journal-title":"J Vasc Surg"},{"key":"B34","doi-asserted-by":"publisher","DOI":"10.2147\/VHRM.S310358","article-title":"Screening for abdominal aortic aneurysms and risk factors in 65-Year-Old men in Oslo, Norway","volume":"17","author":"Rabben","year":"2021","journal-title":"Vasc Health Risk Manage"},{"key":"B35","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1016\/j.ejvs.2020.02.020","article-title":"Diabetes is not associated with the risk of rupture among patients with abdominal aortic aneurysms - results from a Large Danish register based matched case control study from 1996 to 2016","volume":"60","author":"Kristensen","year":"2020","journal-title":"Eur J Vasc Endovasc Surg"},{"key":"B36","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1016\/j.jvs.2018.07.031","article-title":"The association between diabetes and thoracic aortic aneurysms","volume":"69","author":"D\u2019Cruz","year":"2019","journal-title":"J Vasc Surg"},{"key":"B37","doi-asserted-by":"publisher","DOI":"10.1177\/0003319716647626","article-title":"Negative association of diabetes with thoracic aortic dissection and aneurysm","volume":"68","author":"Takagi","year":"2017","journal-title":"Angiology"},{"key":"B38","doi-asserted-by":"publisher","first-page":"599","DOI":"10.1016\/j.ejvs.2006.12.017","article-title":"Negative association between infra-renal aortic diameter and glycaemia: the health in men study","volume":"33","author":"Le","year":"2007","journal-title":"Eur J Vasc Endovasc Surg"},{"key":"B39","doi-asserted-by":"publisher","DOI":"10.1080\/14017431.2017.1319971","article-title":"Aortic diameter at age 65 in men with newly diagnosed type 2 diabetes","volume":"51","author":"Taimour","year":"2017","journal-title":"Scand Cardiovasc J"},{"key":"B40","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejvs.2006.11.011","article-title":"Reduced aortic wall stress in diabetes mellitus","volume":"33","author":"Astrand","year":"2007","journal-title":"Eur J Vasc Endovasc Surg"},{"key":"B41","doi-asserted-by":"publisher","DOI":"10.1016\/j.jvs.2012.05.078","article-title":"Effects of diabetes on small aortic aneurysms under surveillance according to a subgroup analysis from a randomized trial","volume":"56","author":"De Rango","year":"2012","journal-title":"J Vasc Surg"},{"key":"B42","doi-asserted-by":"publisher","DOI":"10.1161\/ATVBAHA.116.308874","article-title":"Glycated hemoglobin is associated with the growth rate of abdominal aortic aneurysms: A substudy from the VIVA (Viborg vascular) randomized screening trial","volume":"37","author":"Kristensen","year":"2017","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"B43","doi-asserted-by":"publisher","DOI":"10.1016\/j.vph.2014.11.006","article-title":"A retrospective study: Factors associated with the risk of abdominal aortic aneurysm rupture","author":"Gokani","year":"2015","journal-title":"Vascul Pharmacol"},{"key":"B44","doi-asserted-by":"publisher","first-page":":19395","DOI":"10.1038\/s41598-021-98893-x","article-title":"Nationwide study in France investigating the impact of diabetes on mortality in patients undergoing abdominal aortic aneurysm repair","volume":"11","author":"Raffort J","year":"2021","journal-title":"Sci Rep"},{"key":"B45","doi-asserted-by":"publisher","DOI":"10.1177\/1479164116651389","article-title":"Negative association of diabetes with rupture of abdominal aortic aneurysm","volume":"13","author":"Takagi","year":"2016","journal-title":"Diabetes Vasc Dis Res"},{"key":"B46","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1177\/1538574413505921","article-title":"Diabetes mellitus and aortic aneurysm rupture: A favorable association","volume":"48","author":"Theivacumar","year":"2014","journal-title":"Vasc Endovascular Surg"},{"key":"B47","doi-asserted-by":"publisher","DOI":"10.1177\/1479164117710391","article-title":"Diabetes mellitus increases the risk of ruptured abdominal aortic aneurysms","volume":"14","author":"Wierzba","year":"2017","journal-title":"Diabetes Vasc Dis Res"},{"key":"B48","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1016\/j.amjsurg.2007.11.022","article-title":"The role of estrogen in the formation of experimental abdominal aortic aneurysm","volume":"197","author":"Wu","year":"2009","journal-title":"Am J Surgery."},{"key":"B49","doi-asserted-by":"publisher","DOI":"10.1161\/01.ATV.0000143386.26399.84","article-title":"Gender differences in experimental aortic aneurysm formation","volume":"24","author":"Ailawadi","year":"2004","journal-title":"Arteriosclerosis Thrombosis Vasc Biol"},{"key":"B50","doi-asserted-by":"publisher","first-page":"341","DOI":"10.1016\/j.jvs.2010.12.069","article-title":"Reproductive history in women with abdominal aortic aneurysms","volume":"54","author":"Villard","year":"2011","journal-title":"J Vasc Surg"},{"key":"B51","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2021.726107","article-title":"A novel hypothesis: A role for follicle stimulating hormone in abdominal aortic aneurysm development in postmenopausal women","volume":"12","author":"Tedjawirja VN","year":"2021","journal-title":"Front Endocrinol (Lausanne)."},{"key":"B52","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1053\/j.semvascsurg.2022.02.007","article-title":"An assessment of the current medical management of thoracic aortic disease: A patient-centered scoping literature review","volume":"35","author":"Pena","year":"2022","journal-title":"Semin Vasc Surg"},{"key":"B53","doi-asserted-by":"publisher","DOI":"10.1002\/bjs.10587","article-title":"Association between metformin prescription and growth rates of abdominal aortic aneurysms","volume":"104","author":"Golledge","year":"2017","journal-title":"Br J Surg"},{"key":"B54","doi-asserted-by":"publisher","first-page":"8502059","DOI":"10.1155\/2022\/8502059","article-title":"Dapagliflozin ameliorates the formation and progression of experimental abdominal aortic aneurysms by reducing aortic inflammation in mice","volume":"2022","author":"Liu","year":"2022","journal-title":"Oxid Med Cell Longev"},{"key":"B55","doi-asserted-by":"publisher","first-page":"768","DOI":"10.1016\/j.jvs.2017.01.070","article-title":"Metformin treatment does not affect the risk of ruptured abdominal aortic aneurysms","volume":"66","author":"Kristensen","year":"2017","journal-title":"J Vasc Surg"},{"key":"B56","doi-asserted-by":"publisher","first-page":"10760296221120423","DOI":"10.1177\/10760296221120423","article-title":"Pharmacotherapy in clinical trials for abdominal aortic aneurysms: A systematic review and meta-analysis","volume":"28","author":"Su","year":"2022","journal-title":"Clin Appl Thromb Hemost."},{"key":"B57","doi-asserted-by":"publisher","DOI":"10.1016\/j.lfs.2019.05.055","article-title":"Type 2 diabetes mellitus reduces clinical complications and mortality in Stanford type b aortic dissection after thoracic endovascular aortic repair: A 3-year follow-up study","volume":"230","author":"Liu","year":"2019","journal-title":"Life Sci"},{"key":"B58","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1016\/j.ejvs.2018.07.035","article-title":"Metformin prescription is associated with a reduction in the combined incidence of surgical repair and rupture related mortality in patients with abdominal aortic aneurysm","volume":"57","author":"Golledge","year":"2019","journal-title":"Eur J Vasc Endovasc Surg"},{"key":"B59","doi-asserted-by":"publisher","first-page":"710\u2013716.e3","DOI":"10.1016\/j.jvs.2018.06.194","article-title":"Metformin prescription status and abdominal aortic aneurysm disease progression in the U.S. veteran population","volume":"69","author":"Itoga NK","year":"2019","journal-title":"J Vasc Surg"},{"key":"B60","doi-asserted-by":"publisher","DOI":"10.18632\/oncotarget.21608","article-title":"Effect of AMPK signal pathway on pathogenesis of abdominal aortic aneurysms","volume":"8","author":"Yang","year":"2017","journal-title":"Oncotarget"},{"key":"B61","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1016\/j.jvs.2016.02.020","article-title":"Metformin treatment status and abdominal aortic aneurysm disease progression","volume":"64","author":"Fujimura","year":"2016","journal-title":"J Vasc Surg"},{"key":"B62","doi-asserted-by":"publisher","DOI":"10.1016\/j.avsg.2020.06.039","article-title":"Metformin prescription associated with reduced abdominal aortic aneurysm growth rate and reduced chemokine expression in a Swedish cohort","volume":"70","author":"Unosson","year":"2021","journal-title":"Ann Vasc Surg"},{"key":"B63","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1016\/j.jvssci.2020.11.031","article-title":"Inhibition of angiotensin-induced aortic aneurysm by metformin in apolipoprotein e-deficient mice","volume":"2","author":"Kunath","year":"2021","journal-title":"JVS Vasc Sci"},{"key":"B64","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1016\/j.jvs.2017.10.044","article-title":"The society for vascular surgery practice guidelines on the care of patients with an abdominal aortic aneurysm","volume":"67","author":"Chaikof","year":"2018","journal-title":"J Vasc Surg"},{"key":"B65","doi-asserted-by":"publisher","first-page":"E78","DOI":"10.1503\/cmaj.090550","article-title":"Five things to know about \u2026 metformin and intravenous contrast","volume":"185","author":"Baerlocher","year":"2013","journal-title":"CMAJ"},{"key":"B66","doi-asserted-by":"publisher","DOI":"10.3892\/mmr.2018.9311","article-title":"PPARgamma agonist rosiglitazone alters the temporal and spatial distribution of inflammation during abdominal aortic aneurysm formation","volume":"18","author":"Wang","year":"2018","journal-title":"Mol Med Rep"},{"key":"B67","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCULATIONAHA.109.852467","article-title":"Rosiglitazone reduces the development and rupture of experimental aortic aneurysms","volume":"119","author":"Jones","year":"2009","journal-title":"Circulation"},{"key":"B68","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1016\/j.atherosclerosis.2012.07.034","article-title":"Rosiglitazone negatively regulates c-jun n-terminal kinase and toll-like receptor 4 proinflammatory signalling during initiation of experimental aortic aneurysms","volume":"225","author":"Pirianov","year":"2012","journal-title":"Atherosclerosis"},{"key":"B69","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1159\/000430986","article-title":"Pioglitazone identifies a new target for aneurysm treatment: Role of Egr1 in an experimental murine model of aortic aneurysm","volume":"52","author":"Charolidi","year":"2015","journal-title":"J Vasc Res"},{"key":"B70","doi-asserted-by":"publisher","DOI":"10.1111\/bph.15411","article-title":"Inactivation of SERCA2 Cys(674) accelerates aortic aneurysms by suppressing PPARgamma","volume":"178","author":"Que","year":"2021","journal-title":"Br J Pharmacol"},{"key":"B71","doi-asserted-by":"publisher","DOI":"10.1016\/j.avsg.2020.03.001","article-title":"Different drugs effect on mesenchymal stem cells isolated from abdominal aortic aneurysm","volume":"67","author":"Pini","year":"2020","journal-title":"Ann Vasc Surg"},{"key":"B72","doi-asserted-by":"publisher","DOI":"10.1007\/s11748-015-0576-1","article-title":"PPAR-gamma agonist attenuates inflammation in aortic aneurysm patients","volume":"63","author":"Motoki","year":"2015","journal-title":"Gen Thorac Cardiovasc Surg"},{"key":"B73","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0227889","article-title":"Dipeptidyl peptidase-4 is increased in the abdominal aortic aneurysm vessel wall and is associated with aneurysm disease processes","volume":"15","author":"Lindquist Liljeqvist","year":"2020","journal-title":"PloS One"},{"key":"B74","doi-asserted-by":"publisher","first-page":"1217","DOI":"10.1016\/j.jvs.2016.05.093","article-title":"A potential contribution of dipeptidyl peptidase-4 by the mediation of monocyte differentiation in the development and progression of abdominal aortic aneurysms","volume":"66","author":"Lu","year":"2017","journal-title":"J Vasc Surg"},{"key":"B75","doi-asserted-by":"publisher","DOI":"10.1016\/j.biochi.2018.06.026","article-title":"Glucagon-like peptide-1: A new therapeutic target to treat abdominal aortic aneurysm","volume":"152","author":"Raffort","year":"2018","journal-title":"Biochimie"},{"key":"B76","doi-asserted-by":"publisher","DOI":"10.1016\/j.jvs.2013.04.048","article-title":"Orally administered dipeptidyl peptidase-4 inhibitor (alogliptin) prevents abdominal aortic aneurysm formation through an antioxidant effect in rats","volume":"59","author":"Bao","year":"2014","journal-title":"J Vasc Surgery."},{"key":"B77","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0121077","article-title":"Dipeptidyl peptidase-4 inhibitor decreases abdominal aortic aneurysm formation through GLP-1-dependent monocytic activity in mice","volume":"10","author":"Lu","year":"2015","journal-title":"PloS One"},{"key":"B78","doi-asserted-by":"publisher","first-page":"698","DOI":"10.5551\/jat.42481","article-title":"Suppression of abdominal aortic aneurysm formation in mice by teneligliptin, a dipeptidyl peptidase-4 inhibitor","volume":"25","author":"Takahara","year":"2018","journal-title":"J Atheroscler Thromb"},{"key":"B79","doi-asserted-by":"publisher","DOI":"10.1007\/s00595-015-1287-z","article-title":"Glucagon-like peptide-1 prevented abdominal aortic aneurysm development in rats","volume":"46","author":"Yu","year":"2016","journal-title":"Surg Today"},{"key":"B80","doi-asserted-by":"publisher","DOI":"10.1161\/ATVBAHA.119.312659","article-title":"SGLT-2 (Sodium-glucose cotransporter 2) inhibition reduces ang II (Angiotensin II)-induced dissecting abdominal aortic aneurysm in ApoE (Apolipoprotein e) knockout mice","volume":"39","author":"Ortega","year":"2019","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"B81","doi-asserted-by":"publisher","DOI":"10.1016\/j.jvs.2013.10.057","article-title":"Postdischarge outcomes after endovascular abdominal aortic aneurysm repair","volume":"59","author":"Gupta","year":"2014","journal-title":"J Vasc Surg"},{"key":"B82","doi-asserted-by":"publisher","first-page":"763","DOI":"10.1016\/j.jvs.2018.05.240","article-title":"Outcomes associated with hyperglycemia after abdominal aortic aneurysm repair","volume":"69","author":"Tarbunou","year":"2019","journal-title":"J Vasc Surgery."},{"key":"B83","doi-asserted-by":"publisher","DOI":"10.1016\/j.jdiacomp.2015.12.015","article-title":"Abdominal aortic aneurysms\u2013glycaemic status and mortality","volume":"30","author":"Hjellestad","year":"2016","journal-title":"J Diabetes Complications."},{"key":"B84","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejvs.2013.12.007","article-title":"Diabetes and abdominal aortic aneurysms","volume":"47","author":"De Rango","year":"2014","journal-title":"Eur J Vasc Endovasc Surg"}],"container-title":["Frontiers in Endocrinology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fendo.2022.1095608\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,16]],"date-time":"2022-12-16T05:17:29Z","timestamp":1671167849000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fendo.2022.1095608\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,12,16]]},"references-count":84,"alternative-id":["10.3389\/fendo.2022.1095608"],"URL":"https:\/\/doi.org\/10.3389\/fendo.2022.1095608","relation":{},"ISSN":["1664-2392"],"issn-type":[{"value":"1664-2392","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,12,16]]},"article-number":"1095608"}}